Literature DB >> 28428835

Aqueous Plasma Pharmacy: Preparation Methods, Chemistry, and Therapeutic Applications.

Jessica M Joslin1, James R McCall1, Justin P Bzdek1, Derek C Johnson1, Brooks M Hybertson1,2.   

Abstract

Plasma pharmacy is a subset of the broader field of plasma medicine. Although not strictly defined, the term aqueous plasma pharmacy (APP) is used to refer to the generation and distribution of reactive plasma-generated species in an aqueous solution followed by subsequent administration for therapeutic benefits. APP attempts to harness the therapeutic effects of plasma-generated oxidant species within aqueous solution in various applications, such as disinfectant solutions, cell proliferation related to wound healing, and cancer treatment. The subsequent use of plasma-generated solutions in the APP approach facilitates the delivery of reactive plasma species to internal locations within the body. Although significant efforts in the field of plasma medicine have concentrated on employing direct plasma plume exposure to cells or tissues, here we focus specifically on plasma discharge in aqueous solution to render the solution biologically active for subsequent application. Methods of plasma discharge in solution are reviewed, along with aqueous plasma chemistry and the applications for APP. The future of the field also is discussed regarding necessary research efforts that will enable commercialization for clinical deployment.

Entities:  

Keywords:  aqueous plasma pharmacy; plasma medicine; plasma pharmacy; plasma-activated medium; plasma-activated solution; plasma-stimulated medium

Year:  2016        PMID: 28428835      PMCID: PMC5394942          DOI: 10.1615/PlasmaMed.2016018618

Source DB:  PubMed          Journal:  Plasma Med        ISSN: 1947-5764


  78 in total

1.  Portable plasma medical device for infection treatment.

Authors:  Magesh Thiyagarajan; Lillian Waldbeser
Journal:  Stud Health Technol Inform       Date:  2012

2.  Induction of apoptosis in human myeloid leukemia cells by remote exposure of resistive barrier cold plasma.

Authors:  Magesh Thiyagarajan; Heather Anderson; Xavier F Gonzales
Journal:  Biotechnol Bioeng       Date:  2013-09-30       Impact factor: 4.530

3.  The topical use of non-thermal dielectric barrier discharge (DBD): nitric oxide related effects on human skin.

Authors:  Kiara Heuer; Martin A Hoffmanns; Erhan Demir; Sabrina Baldus; Christine M Volkmar; Mirco Röhle; Paul C Fuchs; Peter Awakowicz; Christoph V Suschek; Christian Opländer
Journal:  Nitric Oxide       Date:  2014-11-27       Impact factor: 4.427

4.  15-μm-sized single-cellular-level and cell-manipulatable microplasma jet in cancer therapies.

Authors:  Jae Young Kim; Yanzhang Wei; Jinhua Li; Sung-O Kim
Journal:  Biosens Bioelectron       Date:  2010-07-17       Impact factor: 10.618

5.  Microbial inactivation using plasma-activated water obtained by gliding electric discharges.

Authors:  G Kamgang-Youbi; J-M Herry; T Meylheuc; J-L Brisset; M-N Bellon-Fontaine; A Doubla; M Naïtali
Journal:  Lett Appl Microbiol       Date:  2009-01       Impact factor: 2.858

6.  Treatment of methyl tert-butyl ether contaminated water using a dense medium plasma reactor: a mechanistic and kinetic investigation.

Authors:  Derek C Johnson; Vasgen A Shamamian; John H Callahan; Ferencz S Denes; Sorin O Manolache; David S Dandy
Journal:  Environ Sci Technol       Date:  2003-10-15       Impact factor: 9.028

7.  Electric discharge during electrosurgery.

Authors:  Alexey Shashurin; David Scott; Taisen Zhuang; Jerome Canady; Isak I Beilis; Michael Keidar
Journal:  Sci Rep       Date:  2015-04-16       Impact factor: 4.379

8.  Targeting the cancer cell cycle by cold atmospheric plasma.

Authors:  O Volotskova; T S Hawley; M A Stepp; M Keidar
Journal:  Sci Rep       Date:  2012-09-06       Impact factor: 4.379

9.  Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model.

Authors:  Laura Brullé; Marc Vandamme; Delphine Riès; Eric Martel; Eric Robert; Stéphanie Lerondel; Valérie Trichet; Serge Richard; Jean-Michel Pouvesle; Alain Le Pape
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.

Authors:  Rafael Guerrero-Preston; Takenori Ogawa; Mamoru Uemura; Gary Shumulinsky; Blanca L Valle; Francesca Pirini; Rajani Ravi; David Sidransky; Michael Keidar; Barry Trink
Journal:  Int J Mol Med       Date:  2014-07-11       Impact factor: 4.101

View more
  2 in total

1.  Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells.

Authors:  Amalia Azzariti; Rosa Maria Iacobazzi; Roberta Di Fonte; Letizia Porcelli; Roberto Gristina; Pietro Favia; Francesco Fracassi; Ilaria Trizio; Nicola Silvestris; Gabriella Guida; Stefania Tommasi; Eloisa Sardella
Journal:  Sci Rep       Date:  2019-03-11       Impact factor: 4.379

2.  Direct Exposure of Dry Enzymes to Atmospheric Pressure Non-Equilibrium Plasmas: The Case of Tyrosinase.

Authors:  Annamaria Lapenna; Fiorenza Fanelli; Francesco Fracassi; Vincenza Armenise; Valeria Angarano; Gerardo Palazzo; Antonia Mallardi
Journal:  Materials (Basel)       Date:  2020-05-09       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.